<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26633866</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1050</ISSN><JournalIssue CitedMedium="Internet"><Volume>24 Suppl 2</Volume><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Health economics</Title><ISOAbbreviation>Health Econ</ISOAbbreviation></Journal><ArticleTitle>Parameter Heterogeneity In Breast Cancer Cost Regressions - Evidence From Five European Countries.</ArticleTitle><Pagination><MedlinePgn>23-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/hec.3274</ELocationID><Abstract><AbstractText>We investigate parameter heterogeneity in breast cancer 1-year cumulative hospital costs across five European countries as part of the EuroHOPE project. The paper aims to explore whether conditional mean effects provide a suitable representation of the national variation in hospital costs. A cohort of patients with a primary diagnosis of invasive breast cancer (ICD-9 codes 174 and ICD-10 C50 codes) is derived using routinely collected individual breast cancer data from Finland, the metropolitan area of Turin (Italy), Norway, Scotland and Sweden. Conditional mean effects are estimated by ordinary least squares for each country, and quantile regressions are used to explore heterogeneity across the conditional quantile distribution. Point estimates based on conditional mean effects provide a good approximation of treatment response for some key demographic and diagnostic specific variables (e.g. age and ICD-10 diagnosis) across the conditional quantile distribution. For many policy variables of interest, however, there is considerable evidence of parameter heterogeneity that is concealed if decisions are based solely on conditional mean results. The use of quantile regression methods reinforce the need to consider beyond an average effect given the greater recognition that breast cancer is a complex disease reflecting patient heterogeneity.</AbstractText><CopyrightInformation>Copyright © 2015 John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banks</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Research on Health and Social Care Management, CERGAS, Bocconi University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douglas</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Eilidh</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Lothian Analytical Services, NHS Lothian, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCallum</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NHS Lothian, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moger</LastName><ForeName>Tron Anders</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peltola</LastName><ForeName>Mikko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Health and Social Economics (CHESS), National Institute for Health and Welfare, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sveréus</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Management Centre, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Linda J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forbes</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Research Institute, University of Limerick, Limerick, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>EuroHOPE study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Econ</MedlineTA><NlmUniqueID>9306780</NlmUniqueID><ISSNLinking>1057-9230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="N">Hospital Costs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017059" MajorTopicYN="N">Models, Econometric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">breast cancer</Keyword><Keyword MajorTopicYN="N">cost distribution</Keyword><Keyword MajorTopicYN="N">parameter heterogeneity</Keyword><Keyword MajorTopicYN="N">quantile regression</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>09</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>09</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26633866</ArticleId><ArticleId IdType="doi">10.1002/hec.3274</ArticleId><ArticleId IdType="pmc">PMC5063195</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Health Stat Q. 2008 Summer;(38):33-46</Citation><ArticleIdList><ArticleId IdType="pubmed">18595386</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Jun 09;342:d3399</Citation><ArticleIdList><ArticleId IdType="pubmed">21659366</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2015 Dec;24 Suppl 2:23-37</Citation><ArticleIdList><ArticleId IdType="pubmed">26633866</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2010 Aug 11;341:c4112</Citation><ArticleIdList><ArticleId IdType="pubmed">20702551</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast Cancer Res. 2004;6(6):229-39</Citation><ArticleIdList><ArticleId IdType="pubmed">15535852</ArticleId></ArticleIdList></Reference><Reference><Citation>Breast. 2013 Jun;22(3):289-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22841480</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 1998 Jun;17(3):247-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10180918</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Cancer. 2013 Apr;49(6):1374-403</Citation><ArticleIdList><ArticleId IdType="pubmed">23485231</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2013 Feb 1;132(3):676-85</Citation><ArticleIdList><ArticleId IdType="pubmed">22623157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Oncol. 2007 Sep;8(9):773-83</Citation><ArticleIdList><ArticleId IdType="pubmed">17714991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2008 Jun;19(6):1187-94</Citation><ArticleIdList><ArticleId IdType="pubmed">18325921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Oncol. 2008 May;19(5):1009-18</Citation><ArticleIdList><ArticleId IdType="pubmed">18296422</ArticleId></ArticleIdList></Reference><Reference><Citation>Stat Med. 2004 Apr 30;23(8):1311-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15083485</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2001 Jul;20(4):461-94</Citation><ArticleIdList><ArticleId IdType="pubmed">11469231</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2011 Oct;121(10):3786-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21965334</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2012 Oct;21(10):1201-16</Citation><ArticleIdList><ArticleId IdType="pubmed">21905152</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31755206</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1050</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>02</Month></PubDate></JournalIssue><Title>Health economics</Title><ISOAbbreviation>Health Econ</ISOAbbreviation></Journal><ArticleTitle>Do hospitals respond to decreasing prices by supplying more services?</ArticleTitle><Pagination><MedlinePgn>209-222</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/hec.3973</ELocationID><Abstract><AbstractText>Regulated prices are common in markets for medical care. We estimate the effect of changes in regulated reimbursement prices on volume of hospital care based on a reform of hospital financing in Germany. Uniquely, this reform changed the overall level of reimbursement-with increasing prices for some hospitals and decreasing prices for others-without directly affecting the relative prices for different groups of patients or types of treatment. Based on administrative data, we find that hospitals react to increasing prices by decreasing the service supply and to decreasing prices by increasing the service supply. Moreover, we find some evidence that volume changes for hospitals with different price changes are nonlinear. We interpret our findings as evidence for a negative income effect of prices on volume of care.</AbstractText><CopyrightInformation>© 2019 The Authors. Health Economics published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salm</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4739-8741</Identifier><AffiliationInfo><Affiliation>Department of Econometrics and Operations Research, Tilburg University, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wübker</LastName><ForeName>Ansgar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7159-2846</Identifier><AffiliationInfo><Affiliation>Health Department, RWI - Leibniz-Institute for Economics Research, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LSCR - Leibniz Science Campus Ruhr, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Econ</MedlineTA><NlmUniqueID>9306780</NlmUniqueID><ISSNLinking>1057-9230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005377" MajorTopicYN="N">Financial Management, Hospital</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005380" MajorTopicYN="N">Financing, Government</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006301" MajorTopicYN="N">Health Services Needs and Demand</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007349" MajorTopicYN="N">Insurance, Health, Reimbursement</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">government expenditures and health</Keyword><Keyword MajorTopicYN="Y">hospital care</Keyword><Keyword MajorTopicYN="Y">procurement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31755206</ArticleId><ArticleId IdType="doi">10.1002/hec.3973</ArticleId><ArticleId IdType="pmc">PMC7004180</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Health Econ. 1991;10(4):385-410</Citation><ArticleIdList><ArticleId IdType="pubmed">10117011</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2015 Sep;43:13-26</Citation><ArticleIdList><ArticleId IdType="pubmed">26114589</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2012 Sep;31(5):730-43</Citation><ArticleIdList><ArticleId IdType="pubmed">22854178</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 1998 Dec;17(6):675-99</Citation><ArticleIdList><ArticleId IdType="pubmed">10339248</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2020 Feb;29(2):209-222</Citation><ArticleIdList><ArticleId IdType="pubmed">31755206</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Econ. 2016 May;25(5):620-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25929559</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Econ Rev. 2014 Apr;104(4):1320-1349</Citation><ArticleIdList><ArticleId IdType="pubmed">25170174</ArticleId></ArticleIdList></Reference><Reference><Citation>J Health Econ. 2014 May;35:162-78</Citation><ArticleIdList><ArticleId IdType="pubmed">24709038</ArticleId></ArticleIdList></Reference><Reference><Citation>Rand J Econ. 1996 Spring;27(1):99-123</Citation><ArticleIdList><ArticleId IdType="pubmed">10160536</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 1983 Aug;21(8):803-15</Citation><ArticleIdList><ArticleId IdType="pubmed">6350746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>